DECREASED VIRULENCE OF RECOMBINANT VACCINIA VIRUS EXPRESSION VECTORS IS ASSOCIATED WITH A THYMIDINE KINASE-NEGATIVE PHENOTYPE
DECREASED VIRULENCE OF RECOMBINANT VACCINIA VIRUS EXPRESSION VECTORS IS ASSOCIATED WITH A THYMIDINE KINASE-NEGATIVE PHENOTYPE
复制标题
DOI:
10.1038/317813a0
复制
发表时间:
1985-01-01
期刊:
影响因子:
64.8
通讯作者:
MOSS, B
中科院分区:
文献类型:
--
作者:
BULLER, RML;SMITH, GL;MOSS, B
Recent advances in molecular genetics have led to the possibility of using large DNA viruses, such as vaccinia virus, as a biological delivery system for immunizing man against unrelated diseasecausing agents1–7. When live vaccinia virus recombinants expressing the hepatitis B virus surface antigen (HBsAg)8,9, the influenza A virus haemagglutinin10, the herpes simplex virus (HSV) type 1 D glycoprotein11,12, the rabies virus G glycoprotein13,14and the vesicular stomatitis virus G glycoprotein15were used for immunization, animals were protected upon challenge with the appropriate pathogenic agent. A major concern with using such vaccines, however, stems from the previously documented vaccinia virusassociated post-immunizing complications16. We present here experimental evidence that thymidine kinase-negative (TK−) vaccinia virus recombinants, constructed by inserting a variety of DNA coding sequences into the vaccinia virustkgene, are less pathogenic for mice than wild-type virus.